top of page

ProteoFormiX joins the Beerse (Belgium) based JLINX Incubator

  • Oct 16, 2017
  • 1 min read

Updated: Apr 3, 2020

With the launch of JLINX in April 2016, Johnson & Johnson Innovation further expanded the reach and diversity of its company incubation model. Based at the Janssen R&D campus in Beerse, Belgium, this multifaceted initiative is designed to nurture young companies in Europe with the potential to deliver healthcare breakthroughs.


ProteoFormiX is one of the first JLINX residents on the Beerse campus.


Read more

Browse the full report in The Pharma Frontier: digital magazine.

Read the report by Gazet Van Antwerpen online.

 
 
 

Comments


ProteoFormiX.png
  • LinkedIn

powered by:

© 2021 ProteoFormiX

imecistart.png
BlueHealth.png
eithealth.png
FIE-sponsorlogo.png
bottom of page